Researchers at the Kennedy Institute of Rheumatology and the MRC Human Immunology Unit have used 3D and live-imaging to show how resident memory B cells boost antibodies to fight influenza.
Lab sustainability in Oxford was the focus of a seminar for the MRC Weatherall Institute of Molecular Medicine (MRC WIMM) members this Wednesday. The session introduced the Laboratory Efficiency Assessment Framework (LEAF), a nationally recognised scheme to drive reductions in laboratory waste and carbon emissions.
For British Science Week, members of the MRC WIMM visited a local Oxfordshire primary school for an interactive science day \u2013 one of the first of its kind since the start of the pandemic.
New research has identified a new gene that allows cancer cells to survive in the typically acidic microenvironment of a malignant tumour. Researchers have discovered drugs that inhibit the gene in other medical conditions also selectively kill cancer cells at acidic pH, without damaging healthy tissue. This defines a novel strategy for targeting acidic tumour regions.
It is with great sadness that we learnt of the tragic death of Dr Ling Felce, a postdoctoral researcher within Professor Tao Dong's group at the MRC WIMM and MRC HIU, on Tuesday 1st March 2022.
Seven academics in Oxford have been named National Institute of Health Research (NIHR) Senior Investigators in recognition of their outstanding leadership in research.
People who were hospitalised with COVID-19 and continued to experience symptoms five months later, show limited further recovery one year after hospital discharge according to the latest results of a major national study.
A new paper published in Cell Reports by the de Bruijn Group indicates that the onset of circulation triggers a metabolic switch associated with the maturation of haematopoietic stem cells.
![\"Confocal](\"https://www.imm.ox.ac.uk/news/defining-the-role-of-resident-memory-b-cells-in-the-fight-against-influenza/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n